Skip to main content
COVID-19 In Vitro Diagnostic Devices and Test Methods Database

Scientific literature on COVID-19 Test Methods and Devices - detail

Clinical performance of different SARS-CoV-2 IgG antibody tests

Detection Principle
ImmunoAssay-Antibody
Target
IgG, S and N proteins
Testing Method Category
Mixed
Testing Method
Euroimmun (ELISA), Vircell (ELISA), IFA (in-house), Assure Tech (Rapid test), PRNT (in-house)
Testing Method - Additional Info
FaStep (COVID?19 IgG/IgM) rapid test cassettes (COV?W32M, Assure Tech), Euroimmun SARS?CoV?2 IgG ELISA, Vircell COVID?19 ELISA IgG,
Reported Performance
Specificity: 95.7% (Euroimmun), 95.2% (Vircell), 100% (IFA and Assure Tech); Sensitivity: 58.8% (Euroimmun, 5-9days after positive PCR(da+PCR)), 70.6% (Vircell, 5-9da+PCR), 76.5% (IFA and PRNT, 5-9da+PCR), 62.5% (Assur Tech, 5-9da+PCR), 93.8% (Euroimmun and Assure Tech 10-18da+PCR), 100% (Vircell, IFA and PRNT 10-18da+PCR)
Sample Size
33 plasma samples
Peer-reviewed
yes

The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements